Skip to main content
. 2023 Aug 3;14:1218059. doi: 10.3389/fphar.2023.1218059

FIGURE 2.

FIGURE 2

Schematic representation of the molecular mechanism of COVID-19-induced EMT. Angiotensin-converting enzyme 2 (ACE2); Transmembrane serine protease 2 (TMPRSS2); Transforming growth factor-β (TGF-β); Transforming growth factor-β1 (TGF-β1); Interleukin-8 (IL-8); Interleukin-6 (IL-6); Interleukin-1β (IL-1β); Neutrophil gelatinase-associated lipocalin (NGAL); Protease-activated receptor 4 (PAR 4); Zinc-finger E-box-binding 1 (ZEB1); Urokinase-type plasminogen activator receptor (uPAR); Urokinase plasminogen activator (uPA); Anexelekto (AXL).